Intra-host competition between nef–defective escape mutants and wild–type human immunodeficiency virus type 1

Various forms of nef genes with deletions at conserved positions along the sequence have been reported to persist in human immunodeficiency virus type 1 infected patients. We investigate the forces maintaining such variants in the proviral population. The preservation of function and host immune response. The crippled Nef protein might have fewer epitopes, and as such be less visible to the specific immune response, but it will lose some function. Does a trade–off between avoidance of the immune response and loss of function explain the dynamics of the crippled virus found in the patients? To answer this question, we formulated a deterministic model of the virus–host interactions. We found that when the crippled protein presents few epitopes and suffers little loss of function, the two viral types can coexist. Otherwise, the wild–type comes to prevail. The mutant form might initially dominate, but as the selective pressure by the CD8+ T cells decreases over the course of infection, the advantage for the crippled form of losing epitopes disappears. Hence, we go from a situation of coexistence of wild–type and mutant, to a situation of only full–length nef. The results are discussed in the context of the suggested use of live attenuated vaccines having deletions in nef.

[1]  David C. Krakauer,et al.  Effect of Immune Activation on the Dynamics of Human Immunodeficiency Virus Replication and on the Distribution of Viral Quasispecies , 1998, Journal of Virology.

[2]  D. Krakauer,et al.  T–cell induced pathogenesis in HIV: bystander effects and latent infection , 1999, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[3]  K. Sigmund,et al.  On the stabilizing effect of predators and competitors on ecological communities , 1989, Journal of mathematical biology.

[4]  R. Desrosiers,et al.  Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. , 1994, AIDS research and human retroviruses.

[5]  B. Walker,et al.  Systematic Identiflcation of Optimal HIV-1 CTL Epitopes , 1997 .

[6]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[7]  T. Greenough,et al.  Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression. , 1997, Virology.

[8]  L. Loeb,et al.  Fidelity of HIV-1 reverse transcriptase. , 1988, Science.

[9]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[10]  P. Klenerman,et al.  Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Richman,et al.  The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes , 1994, The Journal of experimental medicine.

[12]  Predominance of defective proviral sequences in an HIV + long-term non-progressor. , 1996, Immunology letters.

[13]  R. Redfield,et al.  Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. , 1986, Science.

[14]  Martin A. Nowak,et al.  Antigenic oscillations and shifting immunodominance in HIV-1 infections , 1995, Nature.

[15]  R. Bronson,et al.  Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. , 1995, Science.

[16]  T. Greenough,et al.  High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection , 1996, Journal of virology.

[17]  M. Woolhouse,et al.  Immune avoidance strategies in RNA viruses: fitness continuums arising from trade-offs between immunogenicity and antigenic variability. , 1998, Journal of theoretical biology.

[18]  S. Rowland-Jones,et al.  Strong Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T-Lymphocyte Activity in Sydney Blood Bank Cohort Patients Infected with nef-Defective HIV Type 1 , 1999, Journal of Virology.

[19]  M A Nowak,et al.  Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations. , 1997, Journal of theoretical biology.

[20]  R. Desrosiers,et al.  Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. , 1992, Science.

[21]  H. Clifford Lane,et al.  Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression , 1995, Nature Medicine.

[22]  G. Shaw,et al.  Extensive variation of human immunodeficiency virus type-1 in vivo , 1988, Nature.

[23]  M A Nowak,et al.  Competition between zidovudine‐sensitive and zidovudine‐resistant strains of HIV , 1992, AIDS.

[24]  A. McMichael,et al.  Evasion of Cytotoxic T Lymphocyte (CTL) Responses by Nef-dependent Induction of Fas Ligand (CD95L) Expression on Simian Immunodeficiency Virus–infected Cells , 1997, The Journal of experimental medicine.

[25]  J. Mills,et al.  Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. , 1999, The New England journal of medicine.

[26]  J. Levy,et al.  Identification of multirestricted immunodominant regions recognized by cytolytic T lymphocytes in the human immunodeficiency virus type 1 Nef protein , 1995, Journal of virology.

[27]  J. S. Sullivan,et al.  Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients , 1995, Science.

[28]  Is the Nef protein of HIV-1 required for pathogenesis? , 1996, Trends in microbiology.

[29]  O. Diekmann,et al.  On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations , 1990, Journal of mathematical biology.

[30]  M A Nowak,et al.  Defective escape mutants of HIV. , 1994, Journal of theoretical biology.

[31]  R. Desrosiers,et al.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS , 1991, Cell.

[32]  K Bebenek,et al.  The accuracy of reverse transcriptase from HIV-1. , 1988, Science.

[33]  M. Nowak,et al.  Can live attenuated virus work as post-exposure treatment? , 1995, Immunology today.

[34]  H. Moriyama,et al.  Infectivity and Immunogenicity of SIVmac/HIV‐1 Chimeric Viruses (SHIVs) with Deletions in Two or Three Genes (vpr, nef and vpx) , 1998, Microbiology and immunology.

[35]  M. Nowak,et al.  A mathematical model of vaccination against HIV to prevent the development of AIDS , 1991, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[36]  H. McClure,et al.  Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques , 1999, Nature Medicine.

[37]  M A Nowak,et al.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Fuchs,et al.  Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion. , 1996, Immunology letters.

[39]  R. Swanstrom,et al.  Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo , 1993, Journal of virology.

[40]  B. Berkhout,et al.  Genetic Instability of Live, Attenuated Human Immunodeficiency Virus Type 1 Vaccine Strains , 1999, Journal of Virology.

[41]  A. di Caro,et al.  Grossly Defective nef Gene Sequences in a Human Immunodeficiency Virus Type 1-Seropositive Long-Term Nonprogressor , 1998, Journal of Virology.

[42]  Y. Kuznetsov,et al.  Continuation techniques and interactive software for bifurcation analysis of ODEs and iterated maps: physics , 1993 .

[43]  T. Leitner,et al.  Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  C. Cheng‐Mayer,et al.  HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. , 1994, Immunity.

[45]  S. Frost,et al.  Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV infection , 1994, AIDS.

[46]  A. Whatmore,et al.  Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence , 1995, Journal of virology.

[47]  R. Phillips,et al.  Identification of a novel HLA-A24-restricted cytotoxic T-lymphocyte epitope within HIV-1 Nef. , 1997, AIDS.

[48]  M A Nowak,et al.  The effect of different immune responses on the evolution of virulent CXCR4–tropic HIV , 1998, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[49]  David Looney,et al.  Biologically diverse molecular variants within a single HIV-1 isolate , 1988, Nature.

[50]  D. Montefiori,et al.  Vaccine protection by a triple deletion mutant of simian immunodeficiency virus , 1996, Journal of virology.

[51]  C. Benson,et al.  Viral Dynamics in Human Immunodeficiency Virus Type 1 Infection , 1995 .

[52]  W. Greene,et al.  Unraveling the function of HIV type 1 Nef. , 1996, AIDS research and human retroviruses.

[53]  M. Harris From negative factor to a critical role in virus pathogenesis: the changing fortunes of Nef. , 1996, The Journal of general virology.

[54]  B. Walker,et al.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.

[55]  R. Phillips,et al.  Identification of a novel HLA-B*2705-restricted cytotoxic T-lymphocyte epitope within a conserved region of HIV-1 Nef. , 1997, AIDS.

[56]  D. Trono,et al.  The Nef protein of primate lentiviruses , 1999, Reviews in Medical Virology.

[57]  J. Skowroński,et al.  CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[58]  T. Greenough,et al.  Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1. , 1999, The New England journal of medicine.

[59]  R. May,et al.  Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.

[60]  E. Holmes,et al.  Genetic Drift of Human Immunodeficiency Virus Type 1? , 1998, Journal of Virology.